TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $19,754 | +5.6% | 1,199 | 0.0% | 0.01% | -11.1% |
Q4 2022 | $18,699 | +16.9% | 1,199 | +0.3% | 0.01% | 0.0% |
Q3 2022 | $16,000 | -5.9% | 1,196 | 0.0% | 0.01% | -10.0% |
Q2 2022 | $17,000 | +13.3% | 1,196 | +12.1% | 0.01% | +25.0% |
Q1 2022 | $15,000 | 0.0% | 1,067 | 0.0% | 0.01% | +14.3% |
Q4 2021 | $15,000 | -11.8% | 1,067 | 0.0% | 0.01% | -36.4% |
Q3 2021 | $17,000 | -5.6% | 1,067 | 0.0% | 0.01% | -8.3% |
Q2 2021 | $18,000 | -5.3% | 1,067 | 0.0% | 0.01% | -20.0% |
Q1 2021 | $19,000 | 0.0% | 1,067 | 0.0% | 0.02% | -16.7% |
Q4 2020 | $19,000 | – | 1,067 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |